Health & Fitness News February 5, 2024 Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply February 2, 2024 Fourth-quarter earnings are shaping up to be the best of 2023, but there's a catch February 2, 2024 Here are Jim Cramer’s rapid-fire takeaways on 6 stocks in the news Friday February 2, 2024 Bristol Myers Squibb results top estimates as new drugs post strong sales growth February 1, 2024 Ad giant Publicis paying $350 million to settle U.S. opioid crisis claims February 1, 2024 FUDA Cancer Hospital Introduces Innovative Cancer Treatment Options for Patients in India February 1, 2024 Neuralink competitor Synchron to ramp up brain implant production with equity stake in manufacturer February 1, 2024 Merck results beat expectations as top drugs Keytruda, Gardasil post strong sales January 31, 2024 We're trimming a health-care stock ahead of earnings — hedging our bets on business in China « Previous 1 2 3 4 … 16 17 18 19 20 21 22 23 24 Next »
February 1, 2024 FUDA Cancer Hospital Introduces Innovative Cancer Treatment Options for Patients in India
February 1, 2024 Neuralink competitor Synchron to ramp up brain implant production with equity stake in manufacturer
January 31, 2024 We're trimming a health-care stock ahead of earnings — hedging our bets on business in China